BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7387856)

  • 1. Serum sialic acid and CEA concentrations in human breast cancer.
    Hogan-Ryan A; Fennelly JJ; Jones M; Cantwell B; Duffy MJ
    Br J Cancer; 1980 Apr; 41(4):587-92. PubMed ID: 7387856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer.
    Erbil KM; Jones JD; Klee GG
    Cancer; 1985 Jan; 55(2):404-9. PubMed ID: 3965096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum protein-bound carbohydrates for following the course of disease in patients with metastatic breast carcinoma.
    Waalkes TP; Mrochek JE; Dinsmore SR; Tormey DC
    J Natl Cancer Inst; 1978 Sep; 61(3):703-7. PubMed ID: 278847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients.
    Tredese F; Maggino T; Salvagno L; Marchesoni D; Chizzolini M; Pattaro RF
    Eur J Gynaecol Oncol; 1985; 6(2):136-8. PubMed ID: 4029198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
    Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
    Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of gastric cancer by a combination of tissue polypeptide antigen (TPA), lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA).
    Uehara Y; Kojima O; Ikeda E; Majima T; Nishioka B; Fujita Y; Majima S
    Gastroenterol Jpn; 1984 Oct; 19(5):424-9. PubMed ID: 6519414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients.
    Dnistrian AM; Schwartz MK
    Clin Chem; 1981 Oct; 27(10):1737-9. PubMed ID: 7285326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary versus peripheral blood levels of sialic acid, ferritin, and CEA in patients with breast cancer.
    Monti M; Catania S; Locatelli E; Gandini R; Reggiani A; Cunietti E
    Breast Cancer Res Treat; 1990 Dec; 17(2):77-82. PubMed ID: 2096995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-bound sialic acid as a tumor marker.
    Dnistrian AM; Schwartz MK
    Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.
    Tautu C; Pee D; Dunsmore M; Prorok JJ; Alhadeff JA
    J Clin Lab Anal; 1991; 5(4):247-54. PubMed ID: 1890538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients: clinical correlation with the markers.
    Walach N; Guterman A; Zaidman JL; Kaufman S; Scharf S
    J Surg Oncol; 1989 Feb; 40(2):85-7. PubMed ID: 2915542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of sialic acid concentrations in serum for the diagnosis and staging of breast cancer.
    Riley WM; Tautu C; Verazin G; Gregory J; Josiah S; Prorok JJ; Alhadeff JA
    Clin Chem; 1990 Jan; 36(1):161-2. PubMed ID: 2297916
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer.
    Tjandra JJ; McLaughlin PJ; Russell IS; Collins JP; McKenzie IF
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1633-40. PubMed ID: 3061824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined measurement and significance of lipid-bound sialic acid and carcinoembryonic antigen in detection of human cancer.
    Munjal DD; Picken J; Pritchard J
    Diagn Immunol; 1984; 2(1):36-43. PubMed ID: 6499373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biochemical approach to the staging of human breast cancer.
    Coombes RC; Powles TJ; Gazet JC; Ford HT; Nash AG; Sloane JP; Hillyard CJ; Thomas P; Keyser JW; Marcus D; Zinberg N; Stimson WH; Neville AM
    Cancer; 1977 Aug; 40(2):937-44. PubMed ID: 890676
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lipid-bound sialic acid as a marker in breast cancer.
    Dnistrian AM; Schwartz MK; Katopodis N; Fracchia AA; Stock CC
    Cancer; 1982 Nov; 50(9):1815-9. PubMed ID: 7116306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.